Use of a T cell interferon-γ release assay to evaluate tuberculosis risk in newly qualified physicians in Singapore healthcare institutions

Infection Control and Hospital Epidemiology

Volumn 30, Issue 9, 2009, Pages 870-875

  Chee, C B E ^a,e   Lim, L K Y ^a   Barkham, T M ^b   Koh, D R ^c,d   Lam, S O ^a   Shen, L ^c,d   Wang, Y T ^a  

^a Tuberculosis Control Unit   (Singapore)

^b Department of Laboratory Medicine ^*  (Singapore)

^c TAN TOCK SENG HOSPITAL   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e TB Control Unit   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BCG VACCINATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; FEMALE; HIGH RISK POPULATION; HUMAN; IMMUNE RESPONSE; INFECTION RISK; INTERFERON GAMMA RELEASE ASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; PUBLIC HOSPITAL; SINGAPORE; T LYMPHOCYTE; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS CONTROL;

ADULT; BCG VACCINE; FEMALE; HUMANS; INTERFERON-GAMMA; MALE; MYCOBACTERIUM TUBERCULOSIS; PERSONNEL, HOSPITAL; RISK FACTORS; SINGAPORE; STUDENTS, MEDICAL; T-LYMPHOCYTES; TUBERCULIN TEST; TUBERCULOSIS; YOUNG ADULT;

EID: 70349186553     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/599284     Document Type: Article

References (27)

1. Menzies D, Fanning A, Yuan L, Fitzgerald M. Tuberculosis among health care workers. N Engl J Med 1995; 332:92-98.
2. Sterling TR, Haas DW. Transmission of Mycobacterium tuberculosis from health care workers. N Engl J Med 2006; 355:118-121.
3. Mycobacterium tuberculosis transmission in a newborn nursery and maternity ward-New York City, 2003. MMWR Morb Mortal Wkly Rep 2005; 54:1280-1283.
4. Jensen PA, Lambert LA, Iademarco M, Ridzon R. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR CDC Surveill Summ 2005; 54(RR17):1-141.
5. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000; 161(Suppl 4):S221-S247.
6. Baussano I, Bugiani M, Carosso A, et al. Risk of tuberculin conversion among healthcare workers and the adoption of preventive measures. Occup Environ Med 2007; 64:161-166.
7. Louther J, Rivera P, Feldman J, Villa N, DeHovitz J, Sepkowitz KA. Risk of tuberculin conversion according to occupation among health care workers at a New York City hospital. Am J Respir Crit CareMed 1997; 156: 201-205.
8. Menzies RI. Tuberculin skin testing. In: Reichman LB, Hershfield ES, eds. Tuberculosis: A Comprehensive International Approach. New York, NY: Marcel Dekker; 2000: 279-322.
9. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection-areas of uncertainty and recommendations for research. Ann Intern Med 2007; 146:340-354.
10. Lalvani A. Diagnosing tuberculosis infection in the 21st century. Chest 2007; 131:1898-1906.
11. Centers for Disease Control and Prevention. Guidelines for using the Quantiferon-TB Gold test for detecting Mycobacterium tuberculosis infection, United States (published correction appears in MMWR Morb Mortal Wkly Rep 2005; 54:1288).
12. MMWR Recomm Rep 2005; 54(RR-15): 49-56.
13. National Institute for Health and Clinical Excellence. Clinical Guidelines 33. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. NICE document. London, UK: NICE, 2006:CG33.
14. Pollock NR, Campos-Neto A, Kashino S, et al. Discordant Quanti- FERON-TB Gold test results among US healthcare workers with increased risk of latent tuberculosis infection: a problem or solution? Infect Control Hosp Epidemiol 2008; 29:878-886.
15. Nienhaus A, Schablon A, Le Bacle C, Siano B, Diel R. Evaluation of the interferon-gamma release assay in healthcare workers. Int Arch Occup Environ Health 2008; 81:295-300.
16. Stebler A, Iseli P, Muhlemann K, Bodmer T. Whole blood interferongamma release assay for baseline tuberculosis screening of healthcare workers at a Swiss university hospital. Infect Control Hosp Epidemiol 2008; 29:681-683.
17. Harada N, Nakajima Y, Higuchi K, Sekiya Y, Rothel J, Mori T. Screening for tuberculosis infection using whole-blood interferon-g and Mantoux testing among Japanese healthcare workers. Infect Control Hosp Epidemiol 2006; 27:442-448.
18. Soborg B, Andersen AB, Larsen HK, et al. Detecting a low prevalence of latent tuberculosis among health care workers in Denmark detected by M. tuberculosis specific IFN-g whole-blood test. Scand J Infect Dis 2007; 39:554-559.
19. Pai M, Gokhale K, Joshi R, et al. Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. JAMA 2005; 293: 2746-2755.
20. Pai M, Joshi R, Dogra S, et al. Serial testing of health care workers for tuberculosis using interferon-gamma assay. Am J Respir Crit Care Med 2006; 174:349-355.
21. Pai M, O'Brien R. Serial testing for tuberculosis: can we make sense of T cell assay conversions and reversions? PLoS Med 2007; 4:e208.
22. Ministry of Health, Singapore. Communicable diseases surveillance in Singapore 2007. Ministry of Health report. Singapore: Ministry ofHealth, 2008.
23. Chee CBE, Soh CH, Boudville IC, Chor SS, Wang YT. Interpretation of the tuberculin skin test in Mycobacterium bovis BCG-vaccinated Singaporean schoolchildren. Am J Respir Crit Care Med 2001; 164:958-961.
24. Uplekar M. Stopping tuberculosis: time to turn urgent attention to hospitals. Int J Tuberc Lung Dis 2008; 12:986.
25. Villarino ME, Mazurek G. Tuberculosis contacts, concerns, and controls: what matters for healthcare workers? Infect Control Hosp Epidemiol 2006; 27:433-435.
26. Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald JM. A metaanalysis of the effect of BCG vaccination on tuberculin skin test measurements. Thorax 2002; 57:804-809.
27. Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis 2006; 10:1192-1204.